# SCRIMED Pilot Success Review Command Brief

Status: pilot-success-review-command-active-synthetic-no-roi-guarantee
Updated: 2026-07-09
Review plans: 6
Evidence gaps: 5
Expansion readiness items: 4

## Boundary
SCRIMED Pilot Success Review Command converts synthetic pilot evidence, activation plans, and handoff packets into 30/60/90-day review plans, evidence-gap tracking, expansion readiness, and claims-safe follow-up. It does not authorize live PHI, autonomous clinical care, diagnosis, treatment, prescribing, patient outreach, payer submission, EHR writeback, production deployment, customer activation, audited financial reporting, ROI guarantees, revenue guarantees, profit guarantees, valuation assurance, binding commercial offers, certification claims, securities material, or legal/procurement approval.

This brief is synthetic-only success review planning. It does not authorize live PHI, autonomous clinical care, patient outreach, payer submission, EHR writeback, production deployment, customer activation, audited financial reporting, ROI guarantees, revenue guarantees, profit guarantees, valuation assurance, binding commercial offers, certification claims, securities material, or legal/procurement approval.

## Review Plans
- 30-day workflow-fit review (day-30, ready-for-review): Did the synthetic pilot evidence map to a buyer-recognized workflow problem and owner path? Output: Workflow-fit readiness summary with evidence gaps and retained no-go boundaries.
- 30-day security and governance review (day-30, external-approval-required): Are data boundaries, security contacts, deployment assumptions, and questionnaire blockers documented? Output: Security readiness note with unresolved approval blockers.
- 60-day buyer adoption friction review (day-60, ready-for-review): Which workflow, meeting, documentation, or owner bottlenecks are slowing pilot expansion? Output: Adoption friction map and owner-bound action register.
- 60-day clinical governance review (day-60, blocked-before-claim): Does any buyer-facing language imply clinical authority beyond decision support? Output: Clinical governance posture note with blocked authority claims.
- 90-day commercial readiness review (day-90, review-required): Is there enough reviewed evidence to propose a next scoped paid package without overclaiming outcomes? Output: Claims-safe expansion readiness note and next package recommendation.
- Post-pilot investor proof review (post-pilot, review-required): Which route-backed proof artifacts can support investor diligence without becoming securities material? Output: Investor diligence appendix with proof routes, risks, and next milestones.

## Evidence Gaps
- Buyer reviewer notes are missing or not mapped to evidence packets. (evidence-gap): Keep the outcome narrative internal until reviewer notes are attached. Owner: Customer Success + Delivery Lead
- Security questionnaire or data-boundary disposition is missing. (external-approval-required): Run metadata-only security review and document unresolved external approvals. Owner: Security + Data Governance
- Clinical-facing summary language may be interpreted as clinical authority. (blocked-before-claim): Route through clinical governance and use decision-support-only language. Owner: Clinical Governance
- Commercial summary uses outcome language without sufficient reviewed evidence. (blocked-before-claim): Use measurement-framework language and hold expansion packet for qualified review. Owner: Commercial Operations + Qualified Review
- Implementation owner, cadence, or escalation path is incomplete. (evidence-gap): Resolve owner map before proposing any expansion step. Owner: Implementation Lead

## Expansion Readiness
- Expand from workflow discovery into a paid implementation sprint. (ready-for-review): Prepare a scoped implementation sprint recommendation with qualified review. Blocked: No binding offer, ROI guarantee, staffing reduction claim, or customer activation approval.
- Move security questionnaire support into paid diligence. (external-approval-required): Offer paid diligence support for questionnaire and evidence-room preparation. Blocked: No certification claim, breach guarantee, production connector approval, or live PHI authorization.
- Expand RCM documentation review into a structured prior-authorization readiness package. (external-approval-required): Propose documentation completeness review and draft packet QA. Blocked: No payer submission, claim submission, coverage determination, reimbursement assurance, or payment execution.
- Convert pilot review evidence into an investor diligence appendix. (review-required): Prepare claims-safe diligence appendix after founder and qualified review. Blocked: No securities material, investment advice, valuation assurance, audited financial statement, or fundraising guarantee.

Next best move: Attach reviewer notes to the selected handoff packet, run the evidence-gap checklist, and prepare a claims-safe 30/60/90-day review summary before any buyer or investor distribution.